Long-term outcomes ofintravascular ultrasound-guided drug-eluting stents implantation in patients with acute coronary syndrome:ULTIMATE ACS subgroup  

作　　者：高晓飞 GAO Xiaofei(Dept Cardiol,Nanjing 1st Hosp,Nanjing Med Univ,Nanjing 210006)

机构地区：[1]Dept Cardiol,Nanjing 1st Hosp,Nanjing Med Univ,Nanjing 210006

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第2期95-95,共1页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To explore the long-term effects of intravascular ultrasound(IVUS)guidance on patients with acute coronary syndrome(ACS)undergoing drugeluting stents(DES)implantation.Methods Data used in this study derived from ULTIMATE trial,which was a prospective,multicenter,randomized study.A total of 1448 all-comer patients were enrolled between 2014 August and 2017 May.Primary endpoint of this study was target vessel failure(TVF)at 3 years,including cardiac death,target-vessel-related myocardial infarction,and clinically-driven target vessel revascularization.Results ACS was present in 1136(78.5%)patients,and 3-year clinical follow-up was available in 1423 patients(98.3%).TVF in the ACS group was 9.6%(109/1136),which was significantly higher than 4.5%(14/312)in the non-ACS group(log-rank P=0.005).There were 109 TVFs in the ACS patients,with 7.6%(43/569)TVFs in the IVUS group and 11.6%(66/567)TVFs in the angiography group(log-rank P=0.019).

关 键 词：PATIENTS CORONARY INTRAVASCULAR 

分 类 号：R692[医药卫生—泌尿科学]